Kaitlin Rainwater-Lovett1, Hope Nkamba, Mwangelwa Mubiana-Mbewe, Carolyn B Moore, Joseph Margolick, William J Moss. 1. *Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; †Virology Laboratory, University Teaching Hospital, Lusaka, Zambia; ‡Center for Infectious Disease Research-Zambia, Lusaka, Zambia; §Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL; and ‖Department of W. Harry Feinstone Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (Dr Kaitlin Rainwater-Lovett is now with Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD; Carolyn B. Moore is now with Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, NC).
Abstract
BACKGROUND: Increased exposure to a broad array of pathogens in children residing in sub-Saharan Africa may lead to heightened immune activation and increased proportions of memory T cells. Changes in the size of these cellular subsets have implications for restoration of normal immune function after treatment with highly active antiretroviral therapy (HAART) and are not well characterized in young sub-Saharan African children. METHODS: CD4⁺ and CD8⁺ T-cell subsets were measured by flow cytometry in 157 HIV-infected Zambian children before and at 3-month intervals during HAART for up to 30 months and in 34 control children at a single study visit. RESULTS: Before HAART, HIV-infected children had higher levels of activated and effector memory (EM) CD4⁺ and CD8⁺ T cells, and lower levels of naive T cells and CD8⁺ T cells expressing IL-7Rα, compared with control children. The median duration of follow-up was 14.9 months (interquartile range, 6.4-23.2) among 120 HIV-infected children with at least 1 study follow-up visit. Levels of immune activation and EM CD4⁺ T cells declined within 6 months of HAART, but the percentages of EM CD4 T cells and effector CD8⁺ T cells remained elevated through 30 months of HAART. IL-7Rα-expressing CD8⁺ T cells increased with HAART, suggesting expansion of memory capacity. CONCLUSIONS: HAART significantly reduced levels of immune activation and EM CD4⁺ T cells, and promoted reconstitution of naive T cells and IL-7Rα-expressing CD8⁺ T cells. However, persistently high levels of EM CD4⁺ T cells in HIV-infected children may reflect chronic perturbations in T-cell subset composition.
BACKGROUND: Increased exposure to a broad array of pathogens in children residing in sub-Saharan Africa may lead to heightened immune activation and increased proportions of memory T cells. Changes in the size of these cellular subsets have implications for restoration of normal immune function after treatment with highly active antiretroviral therapy (HAART) and are not well characterized in young sub-Saharan African children. METHODS:CD4⁺ and CD8⁺ T-cell subsets were measured by flow cytometry in 157 HIV-infected Zambian children before and at 3-month intervals during HAART for up to 30 months and in 34 control children at a single study visit. RESULTS: Before HAART, HIV-infectedchildren had higher levels of activated and effector memory (EM) CD4⁺ and CD8⁺ T cells, and lower levels of naive T cells and CD8⁺ T cells expressing IL-7Rα, compared with control children. The median duration of follow-up was 14.9 months (interquartile range, 6.4-23.2) among 120 HIV-infectedchildren with at least 1 study follow-up visit. Levels of immune activation and EM CD4⁺ T cells declined within 6 months of HAART, but the percentages of EM CD4 T cells and effector CD8⁺ T cells remained elevated through 30 months of HAART. IL-7Rα-expressing CD8⁺ T cells increased with HAART, suggesting expansion of memory capacity. CONCLUSIONS: HAART significantly reduced levels of immune activation and EM CD4⁺ T cells, and promoted reconstitution of naive T cells and IL-7Rα-expressing CD8⁺ T cells. However, persistently high levels of EM CD4⁺ T cells in HIV-infectedchildren may reflect chronic perturbations in T-cell subset composition.
Authors: Andrew Prendergast; Maria O'Callaghan; Esse Menson; Djamel Hamadache; Sam Walters; Nigel Klein; Philip Goulder Journal: AIDS Res Hum Retroviruses Date: 2011-09-07 Impact factor: 2.205
Authors: Irina B Mazo; Marek Honczarenko; Harry Leung; Lois L Cavanagh; Roberto Bonasio; Wolfgang Weninger; Katharina Engelke; Lijun Xia; Rodger P McEver; Pandelakis A Koni; Leslie E Silberstein; Ulrich H von Andrian Journal: Immunity Date: 2005-02 Impact factor: 31.745
Authors: Isaac Ssewanyana; Chris A R Baker; Theodore Ruel; Stephanie Bousheri; Moses Kamya; Grant Dorsey; Philip J Rosenthal; Edwin Charlebois; Diane Havlir; Huyen Cao Journal: AIDS Res Hum Retroviruses Date: 2009-01 Impact factor: 2.205
Authors: Isaac Ssewanyana; Mohamed Elrefaei; Grant Dorsey; Theodore Ruel; Norman G Jones; Anne Gasasira; Moses Kamya; Justine Nakiwala; Jane Achan; Edwin Charlebois; Diane Havlir; Huyen Cao Journal: J Infect Dis Date: 2007-10-25 Impact factor: 5.226
Authors: Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly Journal: Nat Med Date: 2009-06-21 Impact factor: 53.440
Authors: Salvador Resino; Elena Seoane; Alicia Pérez; Ezequiel Ruiz-Mateos; Manuel Leal; Maria A Muñoz-Fernández Journal: BMC Infect Dis Date: 2006-07-13 Impact factor: 3.090
Authors: Catherine G Sutcliffe; Kelly Searle; Hellen K Matakala; Michelle P Greenman; Kaitlin Rainwater-Lovett; Philip E Thuma; William J Moss Journal: Pediatr Infect Dis J Date: 2017-03 Impact factor: 2.129
Authors: Landon N Olp; Veenu Minhas; Clement Gondwe; Chipepo Kankasa; Janet Wojcicki; Charles Mitchell; John T West; Charles Wood Journal: J Natl Cancer Inst Date: 2015-07-16 Impact factor: 13.506
Authors: Thomas R Ziegler; Suzanne E Judd; Joshua H Ruff; Grace A McComsey; Allison Ross Eckard Journal: AIDS Res Hum Retroviruses Date: 2017-02-27 Impact factor: 2.205
Authors: Sonwabile Dzanibe; Katie Lennard; Agano Kiravu; Melanie S S Seabrook; Berenice Alinde; Susan P Holmes; Catherine A Blish; Heather B Jaspan; Clive M Gray Journal: J Immunol Date: 2021-11-24 Impact factor: 5.422
Authors: Allison Ross Eckard; Julia C Rosebush; S Thera Lee; Mary Ann O'Riordan; Jakob G Habib; Julie E Daniels; Danielle Labbato; Monika Uribe-Leitz; Ann Chahroudi; Grace A McComsey Journal: Pediatr Infect Dis J Date: 2016-12 Impact factor: 2.129
Authors: Livio Azzoni; Russell Barbour; Emmanouil Papasavvas; Deborah K Glencross; Wendy S Stevens; Mark F Cotton; Avy Violari; Luis J Montaner Journal: PLoS One Date: 2015-12-15 Impact factor: 3.240